George Hlass, MBA, has been named director of Business Development for North America at Fareva API. He will assume responsibility for marketing Fareva’s custom synthesis and manufacturing services to pharmaceutical innovators and biotechnology companies. Fareva’s services include the manufacture of high potent and cytotoxic APIs at EXCELLA GmbH in Feucht Germany, a SafeBridge-certified facility to manufacture both API and oral solid dosages. Mr. Hlass will also promote manufacturing servi...